Azlocillin

CHEMBL1537 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
461.5 g/mol
LogP
0.1
Phase
4

A broad-spectrum acylaminopenicillin antibiotic with enhanced activity against Pseudomonas aeruginosa that disrupts bacterial cell wall synthesis. It has largely been replaced by other antipseudomonal agents.

분자량

461.5000 g/mol

LogP

0.10

TPSA

173.00 Ų

리핀스키 5의 법칙

통과

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O

InChI

InChI=1S/C20H23N5O6S/c1-20(2)13(17(28)29)25-15(27)12(16(25)32-20)22-14(26)11(10-6-4-3-5-7-10)23-19(31)24-9-8-21-18(24)30/h3-7,11-13,16H,8-9H2,1-2H3,(H,21,30)(H,22,26)(H,23,31)(H,28,29)/t11-,12-,13+,16-/m1/s1

Molecular Formula

C20H23N5O6S

HBD / HBA

4 / 7

회전 가능 결합

5

무거운 원자

32

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

A broad-spectrum acylaminopenicillin antibiotic with enhanced activity against Pseudomonas aeruginosa that disrupts bacterial cell wall synthesis. It has largely been replaced by other antipseudomonal agents.

Yes, Azlocillin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1537. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 6479523. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.